Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission

12Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Natural killer (NK)-cell lymphomas are aggressive and relapses occur early. Late relapses are exceptional. Ten relapses 17.5 (11-29) years after first complete remission (CR1) were analyzed. Initial diseases were stage-I (nasal, n = 8; tonsil, n = 1; ileum, n = 1), treated with radiotherapy (n = 6), combined radiotherapy/chemotherapy (n = 3), and chemotherapy (n = 1). Relapse occurred at the same (nasal, n = 6; tonsil, n = 1), adjacent (initial: nasal, relapse: palate; n = 1) or distant (n = 2) sites. Five patients died soon afterwards. Four patients remitted with chemotherapy, two remaining in CR2 (3, 14 years). This series documented the rare late relapses in NK-cell lymphomas, which may still respond to salvage therapy. © 2010 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Au, W. Y., Kim, S. J., Yiu, H. H. Y., Ngan, R. K. C., Loong, F., Kim, W. S., & Kwong, Y. L. (2010). Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission. American Journal of Hematology, 85(5), 362–363. https://doi.org/10.1002/ajh.21663

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free